That sounds reasonable Hesh, look at the all the drugs bought out in the pre clinical stage though. With minimal data. However....
"Intense rivalry over oncology projects means that very few small companies with promising assets make it into phase III before being taken out, hence the low deal volume here; this is probably true to a certain extent in most therapy areas"
We seem to be in the right place on the timeline. Is finding an optimal effective dose rate the final part of a phase 2 trial?? I'm quietly kind of glad there's been no announcement on phase 3 yet.
Cheers
Why IMU is a multi multi bagger, page-6964
-
- There are more pages in this discussion • 19,104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 605784 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 159880 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |